Andrew D. Schiermeier
Equibles does not estimate personal net worth.
Get an email with a short summary when Intellia Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get NTLA alertsAbout Andrew D. Schiermeier
Andrew D. Schiermeier is recorded as COO at Intellia Therapeutics, Inc. (NTLA). The proxy statement of Intellia Therapeutics, Inc. reports total compensation of $1,718,528 for Andrew D. Schiermeier in fiscal 2020, including a base salary of $455,400. Disclosed compensation is on record for 3 fiscal years. Intellia Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Intellia Therapeutics, Inc. includes Edward J. Dulac III (CFO), James Basta (General Counsel), Michael P. Dube (Chief Accounting Officer) and 7 others.
Affiliation history
-
Current
Company network
Leadership on record at Intellia Therapeutics, Inc.
- Edward J. Dulac III CFO
- James Basta General Counsel
- Michael P. Dube Chief Accounting Officer
- Bill Chase Board Member
- Brian Goff Board Member
- Georgia Keresty Board Member
- Georgia Keresty, Ph.D., M.P.H. Board Member
- John M. Leonard Board Member
- John M. Leonard, M.D. Board Member
- Muna Bhanji Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Intellia Therapeutics, Inc. (NTLA) | Executive Vice President, Chief Operating Officer | $455,400 | $1,718,528 |
| 2019 | Intellia Therapeutics, Inc. (NTLA) | Executive Vice President, Chief Operating Officer | $440,000 | $1,227,875 |
| 2018 | Intellia Therapeutics, Inc. (NTLA) | Executive Vice President, Chief Operating Officer | $408,934 | $2,925,306 |
Recent activity
No call appearances or filed executive changes recorded yet.